Clinical expression of systemic lupus erythematosus in patients with C4A deficiency.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 8341140)

Published in Medicine (Baltimore) on July 01, 1993

Authors

M Petri1, R Watson, J A Winkelstein, R H McLean

Author Affiliations

1: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Associated clinical trials:

Lupus Cohort--Thrombotic Events and Coronary Artery Disease | NCT00005436

Articles by these authors

(truncated to the top 100)

Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (N Y) (1993) 22.41

The twisted circular form of polyoma viral DNA. Proc Natl Acad Sci U S A (1965) 20.04

Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A (1991) 16.94

Towards sustainability in world fisheries. Nature (2002) 15.14

Characterization of a cis-Golgi matrix protein, GM130. J Cell Biol (1995) 6.22

Early and late helix-coil transitions in closed circular DNA. The number of superhelical turns in polyoma DNA. J Mol Biol (1968) 4.04

Methadone maintenance in general practice: patients, workload, and outcomes. BMJ (1994) 3.71

Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames. J Virol (1988) 3.51

Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. J Clin Epidemiol (1996) 3.49

Cdc2 kinase directly phosphorylates the cis-Golgi matrix protein GM130 and is required for Golgi fragmentation in mitosis. Cell (1998) 3.36

Milk-borne Scarlet Fever and Tonsillitis. Br Med J (1937) 3.20

Supporting problem drug users: improving methadone maintenance in general practice. Br J Gen Pract (1995) 3.15

GRASP55, a second mammalian GRASP protein involved in the stacking of Golgi cisternae in a cell-free system. EMBO J (1999) 3.14

Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1982) 3.14

Partitioning of the Golgi apparatus during mitosis in living HeLa cells. J Cell Biol (1997) 2.90

Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation. J Immunol (1972) 2.89

Kin recognition between medial Golgi enzymes in HeLa cells. EMBO J (1994) 2.62

Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease. N Engl J Med (1968) 2.61

Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care (1999) 2.52

Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid. J Immunol (1978) 2.40

A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr (1994) 2.39

Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis. J Clin Invest (1973) 2.33

Localization of organelle proteins by isotope tagging (LOPIT). Mol Cell Proteomics (2004) 2.31

Europe and America forge health links. BMJ (1996) 2.24

Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med (1977) 2.23

Conservation. High value and long life--double jeopardy for tunas and billfishes. Science (2011) 2.14

Reassembly of Golgi stacks from mitotic Golgi fragments in a cell-free system. J Cell Biol (1995) 2.10

Nonvenereal transmission of gonococcal infections to children. J Pediatr (1971) 2.06

Surface determinants of Haemophilus influenzae pathogenicity: comparative virulence of capsular transformants in normal and complement-depleted rats. J Infect Dis (1983) 2.06

The role of complement in the host's defense against Streptococcus pneumoniae. Rev Infect Dis (1981) 2.06

The presence of ribonucleotides in mature closed-circular mitochondrial DNA. Proc Natl Acad Sci U S A (1973) 2.05

Dementia in older people: an update. Intern Med J (2014) 2.03

Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum (1991) 1.99

Activation of the alternative pathway by pneumococcal cell walls. J Immunol (1977) 1.89

Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans. J Gen Virol (1988) 1.89

Francisella philomiragia sepsis in chronic granulomatous disease. Pediatr Infect Dis J (1997) 1.88

Isolation of a matrix that binds medial Golgi enzymes. J Cell Biol (1994) 1.87

X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) (1985) 1.85

Dietary intake patterns and sociodemographic factors in the atherosclerosis risk in communities study. ARIC Study Investigators. Prev Med (1994) 1.83

The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus. J Immunol (1976) 1.80

Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med (1991) 1.79

Pseudomonas cepacia: an emerging pathogen in chronic granulomatous disease. J Pediatr (1986) 1.79

The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule. J Immunol (1974) 1.73

Chronic rotavirus infection in immunodeficiency. J Pediatr (1980) 1.66

Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation. N Engl J Med (1987) 1.63

Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function. Blood (2001) 1.60

Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy (2011) 1.59

Sorting by COP I-coated vesicles under interphase and mitotic conditions. J Cell Biol (1996) 1.58

Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest (1998) 1.58

Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall. J Immunol (1980) 1.54

EU adopts tougher safeguards on genetic modification. BMJ (1999) 1.53

Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) (1996) 1.53

Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein. J Clin Endocrinol Metab (1986) 1.52

Randomised controlled trial of effect of Baby Check on use of health services in first 6 months of life. BMJ (1999) 1.51

Neonatal hemodialysis: effective therapy for the encephalopathy of inborn errors of metabolism. J Pediatr (1990) 1.51

Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause (1999) 1.50

Reversed polarity of Na(+) -K(+) -ATPase: mislocation to apical plasma membranes in polycystic kidney disease epithelia. Am J Physiol (1991) 1.49

Frontal lobe neglect in monkeys. Neurology (1995) 1.48

Activation of the alternative complement pathway by Haemophilus influenzae type B. Infect Immun (1977) 1.46

Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion (2001) 1.46

Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics (1998) 1.44

Pityriasis rubra pilaris treated with acitretin and narrow-band ultraviolet B (Re-TL-01) Br J Dermatol (2000) 1.43

Opsonins: their function, identity, and clinical significance. J Pediatr (1973) 1.42

Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass. Ann Thorac Surg (1995) 1.42

Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators. Diabetes Care (1996) 1.40

Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation (1989) 1.40

Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) (1986) 1.38

The effect of complement depletion on the course of Sindbis virus infection in mice. J Immunol (1978) 1.38

The role of C3 as an opsonin in the early stages of infection. Proc Soc Exp Biol Med (1975) 1.38

Health ministers to help orphan drugs. BMJ (1995) 1.36

Reconstitution of B and T lymphocyte function in severe combined immunodeficiency disease after transplantation with thymic epithelium. Lancet (1976) 1.35

Characterization and virulence analysis of catalase mutants of Haemophilus influenzae. Infect Immun (1994) 1.34

Large outbreak of food poisoning caused by Salmonella typhimurium definitive type 49 in mayonnaise. BMJ (1989) 1.34

Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships. Am J Physiol (1999) 1.33

The Drosophila GMII gene encodes a Golgi alpha-mannosidase II. J Cell Sci (1999) 1.32

Carrier detection in the Wiskott Aldrich syndrome. Blood (1988) 1.32

The role of the membrane-spanning domain and stalk region of N-acetylglucosaminyltransferase I in retention, kin recognition and structural maintenance of the Golgi apparatus in HeLa cells. J Cell Sci (1996) 1.32

Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. A pharmacokinetic and functional analysis. J Clin Invest (1985) 1.31

Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med (1986) 1.31

Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis. Infect Immun (1976) 1.29

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group. Pediatrics (2000) 1.26

Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia. J Pediatr (2000) 1.25

Reproducibility of allergen-induced early and late asthmatic responses. J Allergy Clin Immunol (1995) 1.25

The p24 family member p23 is required for early embryonic development. Curr Biol (2000) 1.24

The role of complement in viral infections. II. the clearance of Sindbis virus from the bloodstream and central nervous system of mice depleted of complement. J Infect Dis (1980) 1.23

Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest (1997) 1.23

Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis. Mol Cell Biol (2000) 1.21

Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer (1991) 1.21

Evidence for recycling of the resident medial/trans Golgi enzyme, N-acetylglucosaminyltransferase I, in ldlD cells. J Biol Chem (1995) 1.20

The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus. J Immunol (1980) 1.20

Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance. J Immunol (1981) 1.19

Restricted uptake of ethidium bromide and propidium diiodide by denatured closed circular DNA in buoyant cesium chloride. J Mol Biol (1974) 1.17

The replication and structure of mitochondrial DNA in animal cells. Cold Spring Harb Symp Quant Biol (1974) 1.17

Phase II study of mitoxantrone in epithelial ovarian cancer. Cancer Treat Rep (1987) 1.16

Enzyme-linked immunosorbent assay for detection and quantitation of capsular antigen of Haemophilus influenzae type b. Infect Immun (1978) 1.15

Adenosine deaminase deficiency in adults. Blood (1997) 1.15

Complement and the host's defense against the pneumococcus. Crit Rev Microbiol (1984) 1.15

Community-acquired Acinetobacter calcoaceticus var anitratus pneumonia. JAMA (1977) 1.15

Identification and characterization of Col plasmids from classical colicin E-producing strains. J Bacteriol (1981) 1.14

Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J Pediatr (1997) 1.14